| [1] |
McComb S, Thiriot A, Akache B, Krishnan L, Stark FC. 2025. Introduction to the immune system. In Immunoproteomics. eds. Fulton KM, Twine SM. New York: Springer. pp. 1−31 doi: 10.1007/978-1-0716-4832-2_1 |
| [2] |
Warrick KA, Vallez CN, Meibers HE, Pasare C. 2025. Bidirectional communication between the innate and adaptive immune systems. |
| [3] |
Iwasaki A, Medzhitov R. 2015. Control of adaptive immunity by the innate immune system. |
| [4] |
Wang R, Lan C, Benlagha K, Camara NOS, Miller H, et al. 2024. The interaction of innate immune and adaptive immune system. |
| [5] |
Zhang Q, Cao L, Xu K. 2024. Role and mechanism of lactylation in cancer. |
| [6] |
Zhang D, Tang Z, Huang H, Zhou G, Cui C, et al. 2019. Metabolic regulation of gene expression by histone lactylation. |
| [7] |
Raychaudhuri D, Singh P, Chakraborty B, Hennessey M, Tannir AJ, et al. 2024. Histone lactylation drives CD8+ T cell metabolism and function. |
| [8] |
Ziogas A, Novakovic B, Ventriglia L, Galang N, Tran KA, et al. 2025. Long-term histone lactylation connects metabolic and epigenetic rewiring in innate immune memory. |
| [9] |
Llibre A, Kucuk S, Gope A, Certo M, Mauro C. 2025. Lactate: a key regulator of the immune response. |
| [10] |
Kierans SJ, Taylor CT. 2024. Glycolysis: a multifaceted metabolic pathway and signaling hub. |
| [11] |
Bartoloni B, Mannelli M, Gamberi T, Fiaschi T. 2024. The multiple roles of lactate in the skeletal muscle. Cells 13(14):1177 |
| [12] |
Wu RS, Panusz HT, Hatch CL, Bonner WM. 1986. Histones and their modification. |
| [13] |
Strahl BD, Allis CD. 2000. The language of covalent histone modifications. |
| [14] |
Liu J, Zhao L, Yan M, Jin S, Shang L, et al. 2025. H4K79 and H4K91 histone lactylation, newly identified lactylation sites enriched in breast cancer. |
| [15] |
Li L, Dong J, Xu C, Wang S. 2025. Lactate drives senescence-resistant lineages in hepatocellular carcinoma via histone H2B lactylation of NDRG1. |
| [16] |
Xu H, Li L, Wang S, Wang Z, Qu L, et al. 2023. Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites. |
| [17] |
Li W, Zhou C, Yu L, Hou Z, Liu H, et al. 2024. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. |
| [18] |
Zhang X, Liu Y, Wang N. 2025. Dynamic changes in histone lysine lactylation during meiosis prophase I in mouse spermatogenesis. |
| [19] |
Fan Z, Liu Z, Zhang N, Wei W, Cheng K, et al. 2023. Identification of SIRT3 as an eraser of H4K16la. |
| [20] |
Jiang S, Li H, Zhang L, Mu W, Zhang Y, et al. 2025. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. |
| [21] |
Zhou F, Liu Q, Zhang L, Zhu Q, Wang S, et al. 2020. Selective inhibition of CBP/p300 HAT by A-485 results in suppression of lipogenesis and hepatic gluconeogenesis. |
| [22] |
Niu Z, Chen C, Wang S, Lu C, Wu Z, et al. 2024. HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription. |
| [23] |
Sun S, Xu Z, He L, Shen Y, Yan Y, et al. 2024. Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed α-tubulin lactylation. |
| [24] |
Moreno-Yruela C, Zhang D, Wei W, Bæk M, Liu W, et al. 2022. Class I histone deacetylases (HDAC1−3) are histone lysine delactylases. |
| [25] |
Wei M, Zhao M, Wu X, Wu G. 2025. Functions and mechanisms of Zn2+-dependent histone deacetylase in plant responses to abiotic stress. |
| [26] |
Chen K, Zhang X, Wu YD, Wiest O. 2014. Inhibition and mechanism of HDAC8 revisited. |
| [27] |
Zu H, Li C, Dai C, Pan Y, Ding C, et al. 2022. SIRT2 functions as a histone delactylase and inhibits the proliferation and migration of neuroblastoma cells. |
| [28] |
Du R, Gao Y, Yan C, Ren X, Qi S, et al. 2024. Sirtuin 1/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis. |
| [29] |
Nickel GA, Pederson NJ, Faheem, Yang Z, Bulf J, et al. 2025. Sirtuin 6 is a histone delactylase. Journal of Biological Chemistry 301(12):110795 |
| [30] |
Nuñez R, Sidlowski PFW, Steen EA, Wynia-Smith SL, Sprague DJ, et al. 2024. The TRIM33 bromodomain recognizes histone lysine lactylation. |
| [31] |
Zhai G, Niu Z, Jiang Z, Zhao F, Wang S, et al. 2024. DPF2 reads histone lactylation to drive transcription and tumorigenesis. |
| [32] |
Hu X, Huang X, Yang Y, Sun Y, Zhao Y, et al. 2024. Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader. |
| [33] |
Zhang F, Zhou J, Lu P, Zhang X, Yang L, et al. 2024. Lactylation of histone by BRD4 regulates astrocyte polarization after experimental subarachnoid hemorrhage. |
| [34] |
Jia Z, Lu S, Wang Z, Ge P. 2025. From mechanism to targeted therapy: advances in histone lactylation-driven cancer progression (Review). |
| [35] |
Dai W, Wu G, Liu K, Chen Q, Tao J, et al. 2023. Lactate promotes myogenesis via activating H3K9 lactylation-dependent up-regulation of Neu2 expression. |
| [36] |
Shi L, Li B, Tan J, Zhu L, Zhang S, et al. 2025. Exosomal lncRNA Mir100hg from lung cancer stem cells activates H3K14 lactylation to enhance metastatic activity in non-stem lung cancer cells. |
| [37] |
Yang W, Wang P, Cao P, Wang S, Yang Y, et al. 2021. Hypoxic in vitro culture reduces histone lactylation and impairs pre-implantation embryonic development in mice. |
| [38] |
Feng F, Wu J, Chi Q, Wang S, Liu W, et al. 2024. Lactylome analysis unveils lactylation-dependent mechanisms of stemness remodeling in the liver cancer stem cells. |
| [39] |
Zhao X, Li M, Fu Y, Chen C, Chen Y, et al. 2026. PSMD14-mediated PFKFB2 deubiquitination activates H3K27 lactylation to drive cancer stemness in gastric adenocarcinoma. Cell Death & Differentiation 33(4):813−830 |
| [40] |
Zhao P, Qiao C, Wang J, Zhou Y, Zhang C. 2024. Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell-specific molecule 1 expression. |
| [41] |
Zhang C, Yu R, Li S, Yuan M, Hu T, et al. 2025. KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression. |
| [42] |
Sun C, Li X, Teng Q, Liu X, Song L, et al. 2025. Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation. |
| [43] |
Zang Y, Wang A, Zhang J, Xia M, Jiang Z, et al. 2024. Hypoxia promotes histone H3K9 lactylation to enhance LAMC2 transcription in esophageal squamous cell carcinoma. |
| [44] |
Yue Q, Wang Z, Shen Y, Lan Y, Zhong X, et al. 2024. Histone H3K9 lactylation confers temozolomide resistance in glioblastoma via LUC7L2-mediated MLH1 intron retention. |
| [45] |
Yu ZY, Zhou XX, Cai YQ, Lu TG, Ding MF, et al. 2023. Lactate-mediated histone H3K9 lactylation facilitates tumorigenesis of T-cell lymphoma via activation of SFXN1 expression. |
| [46] |
Ma Y, Feng S, Jiang Y, Jiang J, Liu R, et al. 2026. SLC22A6-dependent lactylation of H3K9 aggravates endothelial dysfunction and atherosclerosis. |
| [47] |
Fan W, Zeng S, Wang X, Wang G, Liao D, et al. 2024. A feedback loop driven by H3K9 lactylation and HDAC2 in endothelial cells regulates VEGF-induced angiogenesis. |
| [48] |
Zhang Y, Wang S, Wu J, Du Q, Yu H, et al. 2025. Gastrodin mitigates aortic valve calcification by inhibiting glycolysis and histone lactylation through interfering with valve interstitial cells. |
| [49] |
Wu G, Yang C, Huang Y, Liu B, Zhai H, et al. 2025. Histone lactylation promotes rheumatoid arthritis progression by increasing NFATc2 expression and the production of anti-lactylated histone autoantibodies. |
| [50] |
Dai Y, Wang S, Luo J, Yu H, Du Q, et al. 2025. Gastrodin attenuates rheumatoid arthritis by targeting KAT8 to inhibit the lactylation of H3K9. |
| [51] |
Gong F, Zheng X, Xu W, Xie R, Liu W, et al. 2025. H3K14la drives endothelial dysfunction in sepsis-induced ARDS by promoting SLC40A1/transferrin-mediated ferroptosis. |
| [52] |
Zeng Y, Jiang H, Chen Z, Xu J, Zhang X, et al. 2025. Histone lactylation promotes multidrug resistance in hepatocellular carcinoma by forming a positive feedback loop with PTEN. |
| [53] |
Zheng P, Mao Z, Luo M, Zhou L, Wang L, et al. 2023. Comprehensive bioinformatics analysis of the solute carrier family and preliminary exploration of SLC25A29 in lung adenocarcinoma. |
| [54] |
Zhang X, Chen J, Lin R, Huang Y, Wang Z, et al. 2024. Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la/KLF5 pathway. |
| [55] |
Sun T, Zhang JN, Lan T, Shi L, Hu L, et al. 2025. H3K14 lactylation exacerbates neuronal ferroptosis by inhibiting calcium efflux following intracerebral hemorrhagic stroke. |
| [56] |
Xiong J, Ge X, Pan D, Zhu Y, Zhou Y, et al. 2025. Metabolic reprogramming in astrocytes prevents neuronal death through a UCHL1/PFKFB3/H4K8la positive feedback loop. |
| [57] |
Wang RR, Chen DL, Wei M, Li SR, Zhou P, et al. 2025. Histone lactylation-induced premature senescence contributes to 1-nitropyrene-Induced chronic obstructive pulmonary disease. |
| [58] |
Xu ZP, Shan SY, Cai EW, Wu YY. 2024. Gegen Qinlian decoction inhibited M1 macrophage polarization and ulcerative colitis progression through regulating histone lactylation. |
| [59] |
Boden KA, Chai J, Kufazvinei TTJ, Choudhury RP. 2026. Trained immunity and cardiovascular risk: an immunological perspective. |
| [60] |
Zhang X, Liu Y, Wang N. 2024. Multifaceted roles of histone lysine lactylation in meiotic gene dynamics and recombination. bioRxiv Preprint: 2024.01.25.576681 |
| [61] |
Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, et al. 2006. Histone H4-K16 acetylation controls chromatin structure and protein interactions. |
| [62] |
Tang S, Liu Y, Jin B, Zhang T, Wang X, et al. 2026. LDHA facilitates immune escape in bladder cancer through H4K5 lactylation-dependent upregulation of PD-L1. |
| [63] |
Huang C, Liu T, Zhao Y, Wang M, Wang D, et al. 2026. Histone H4K8 lactylation modulated immunosuppressive properties by promoting FAP transcription and ECM remodeling. Gastric Cancer 29:70-82 |
| [64] |
Lu B, Chen S, Guan X, Chen X, Du Y, et al. 2025. Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer. |
| [65] |
Li W, Zhang Q, Yin H, Li Q, Liu S, et al. 2025. Knockdown of SUCLG2 inhibits glioblastoma proliferation and promotes apoptosis through LMNA acetylation and the mediation of H4K16la lactylation. |
| [66] |
Yang Y, Wen J, Lou S, Han Y, Pan Y, et al. 2025. DNAJC12 downregulation induces neuroblastoma progression via increased histone H4K5 lactylation. Journal of Molecular Cell Biology 16(11):mjae056 |
| [67] |
Guo Y, Chu L, Shui W, Hu H, Hao L, et al. 2025. Histone lactylation in immune cells and its predictive role in sepsis progression: a prospective observational study. Shock 65(5):792−800 |
| [68] |
Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, et al. 2023. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. |
| [69] |
Cai Q, Deng W, Zou Y, Chen ZS, Tang H. 2025. Histone lactylation as a driver of metabolic reprogramming and immune evasion. |
| [70] |
Li Y, Xiang J, Zhang J, Lin J, Wu Y, et al. 2020. Inhibition of Brd4 by JQ1 Promotes functional recovery from spinal cord injury by activating autophagy. |
| [71] |
Xiao S, Li Y, Wang J, Wang M, Bu B, et al. 2025. Lactylated histone H4K8 regulation of MFN2/Wnt signaling integrates glycolytic metabolism and Müller cell activation in the pathogenesis of glaucoma. |
| [72] |
Huang T, You Q, Liu J, Shen X, Huang D, et al. 2025. WTAP mediated m6a modification stabilizes PDIA3P1 and promotes tumor progression driven by histone lactylation in esophageal squamous cell carcinoma. |
| [73] |
Guo X, Ren X, Yan C, Huang H. 2025. Quantitative proteomics reveals the role of lysine lactylation in lenalidomide-resistance in multiple myeloma cells. |
| [74] |
Duan W, Liu W, Xia S, Zhou Y, Tang M, et al. 2023. Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis. |
| [75] |
Deng J, Li Y, Yin L, Liu S, Li Y, et al. 2025. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. |
| [76] |
Yuan Y, Li S, Ren C, Wang J, Wang Z, et al. 2025. EVA1A facilitates glycolysis in esophageal squamous cell carcinoma to boost PLAU histone lactylation and dampen CD8+ T cell activity. |
| [77] |
Wang X, Ying T, Yuan J, Wang Y, Su X, et al. 2023. BRAFV600E restructures cellular lactylation to promote anaplastic thyroid cancer proliferation. Endocrine-Related Cancer 30(8):e220344 |
| [78] |
Pan RY, He L, Zhang J, Liu X, Liao Y, et al. 2022. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease. |
| [79] |
Wang H, Xia H, Bai J, Wang Z, Wang Y, et al. 2025. H4K12 lactylation-regulated NLRP3 is involved in cigarette smoke-accelerated Alzheimer-like pathology through mTOR-regulated autophagy and activation of microglia. |
| [80] |
Cheng J, Zhao H. 2024. NEK7 induces lactylation in Alzheimer's disease to promote pyroptosis in BV-2 cells. |
| [81] |
Yang Y, Song L, Yu L, Zhang J, Zhang B. 2025. H4K12 lactylation potentiates mitochondrial oxidative stress via the Foxo1 pathway in diabetes-induced cognitive impairment. |
| [82] |
Sun M, Zhang X, Feng X, Liang L. 2025. PKM2 accelerated the progression of chronic fatigue syndrome via promoting the H4K12la/NF-κB induced neuroinflammation and mitochondrial damage. |
| [83] |
Chen LH, Wei JP, Li MD, Lu X, Ma YC, et al. 2025. AhR-mediated histone lactylation drives cellular senescence during benzo[a]pyrene-evoked chronic obstructive pulmonary disease. |
| [84] |
Shen X, Qiao W, Yan W, Xie H, Zhang C, et al. 2025. Keratinocyte-specific H4K12 lactylation drives a non-canonical IL-17-dependent signaling in psoriasis progression in mice. |
| [85] |
Tang Y, Li Y, Yang X, Lu T, Wang X, et al. 2026. Intestinal metabolite TMAO promotes CKD progression by stimulating macrophage M2 polarization through histone H4 lysine 12 lactylation. Cell Death & Differentiation 33(2):314−326 |
| [86] |
Li X, Chen M, Chen X, He X, Li X, et al. 2024. TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation. |
| [87] |
Liu M, Gu L, Zhang Y, Li Y, Zhang L, et al. 2024. LKB1 inhibits telomerase activity resulting in cellular senescence through histone lactylation in lung adenocarcinoma. |
| [88] |
Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ. 1997. Crystal structure of the nucleosome core particle at 2.8 Å resolution. |
| [89] |
Kikuchi M, Morita S, Wakamori M, Sato S, Uchikubo-Kamo T, et al. 2023. Epigenetic mechanisms to propagate histone acetylation by p300/CBP. |
| [90] |
Dai X, Lv X, Thompson EW, Ostrikov K. 2022. Histone lactylation: epigenetic mark of glycolytic switch. |
| [91] |
Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, et al. 2014. mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity. |
| [92] |
Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, et al. 2000. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. |
| [93] |
Gao J, Liu R, Huang K, Li Z, Sheng X, et al. 2025. Dynamic investigation of hypoxia-induced L-lactylation. |
| [94] |
Qu J, Guo X, Wang X, Meng H, Li P, et al. 2025. The significance of trained immunity in cancer. |
| [95] |
Li B, Li J, Zhu Z, Tang Y, Zhou Y, et al. 2025. FGF15/FGFR4 signaling suppresses M1 macrophage polarization and multi-organ inflammation in septic mice by inhibiting H3K18 lactylation-driven Irf7 expression through NF2-Hippo activation. |
| [96] |
Tong Q, Huang C, Tong Q, Zhang Z. 2025. Histone lactylation: a new frontier in laryngeal cancer research (Review). |
| [97] |
Wu P, Zhang J, Jiang Z, Liu X, Jiang N, et al. 2026. Lactate-lactylation in tumor angiogenesis and progression: mechanisms, biomarker potential, and therapeutic implications. |